Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Expert Review of Clinical Immunology|May 19, 2010
Anticalins: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapiesAndreas M Hohlbaum, Arne SkerraClinical Immunology (Orlando, Fla.)|May 4, 2002
Fas-ligand--iron fist or Achilles' heel?Andreas M Hohlbaum, Rebecca R Saff, Ann Marshak-RothsteinJournal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Activation-induced cell death limits effector function of CD4 tumor-specific T cellsRebecca R Saff, Elena S Spanjaard, Andreas M Hohlbaum, et al.Nature|April 12, 2002
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptorsElizabeth A Leadbetter, Ian R Rifkin, Andreas M Hohlbaum, et al.Plos One|October 15, 2013
Improved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoformCoby M M Laarakkers, Erwin T Wiegerinck, Siem Klaver, et al.Angiogenesis|December 10, 2015
Functional characterization of a VEGF-A-targeting Anticalin, prototype of a novel therapeutic human protein classHendrik Gille, Martin Hülsmeyer, Stefan Trentmann, et al.Plos One|May 8, 2014
Multimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalinsReinhard Meier, Rickmer Braren, Yvonne Kosanke, et al.Regulatory Toxicology and Pharmacology : RTP|February 27, 2025
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to considerLise I Loberg, William R Proctor, Andrew D Burdick, et al.British Journal of Pharmacology|January 13, 2018
Sustained plasma hepcidin suppression and iron elevation by Anticalin-derived hepcidin antagonist in cynomolgus monkeyAndreas M Hohlbaum, Hendrik Gille, Stefan Trentmann, et al.Molecular Cancer Therapeutics|September 5, 2013
A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activityShane A Olwill, Christian Joffroy, Hendrik Gille, et al.Pageof 2